Written Exposure Therapy for Suicide Prevention (WET-SP): Design and methodology of a randomized controlled trial among military service members psychiatrically hospitalized for suicide risk
Jaclyn C. Kearns , Ian H. Stanley , Denise M. Sloan , Stacey Young-McCaughan , Hannah C. Tyler , Jennifer M. Hein , Casey L. Straud , Thomas E. Joiner , James W. Pennebaker , M. David Rudd , Alan L. Peterson , Brian P. Marx , for the STRONG STAR Consortium
{"title":"Written Exposure Therapy for Suicide Prevention (WET-SP): Design and methodology of a randomized controlled trial among military service members psychiatrically hospitalized for suicide risk","authors":"Jaclyn C. Kearns , Ian H. Stanley , Denise M. Sloan , Stacey Young-McCaughan , Hannah C. Tyler , Jennifer M. Hein , Casey L. Straud , Thomas E. Joiner , James W. Pennebaker , M. David Rudd , Alan L. Peterson , Brian P. Marx , for the STRONG STAR Consortium","doi":"10.1016/j.cct.2025.108001","DOIUrl":null,"url":null,"abstract":"<div><div>Military service members admitted to inpatient psychiatry for self-injurious thoughts and behaviors (SITBs) represent an at-risk group for continued SITBs and rehospitalizations in the post-hospital discharge period. Yet, there is a paucity of evidence-based interventions designed to be delivered on inpatient psychiatric units to reduce the risk of post-discharge SITBs. To address this gap, our group developed Written Exposure Therapy for Suicide Prevention (WET-SP), which is based on the written disclosure paradigm. This paper describes the design, methodology, and protocol of a randomized controlled trial. The primary objective of this study is to evaluate the efficacy of a novel, brief, scalable, cognitive behavioral therapy—WET-SP—in reducing the incidence and severity of SITBs in active duty military service members, veterans, and their adult military beneficiaries following a psychiatric hospitalization due to suicide ideation, suicide plans, or a suicide attempt.</div></div>","PeriodicalId":10636,"journal":{"name":"Contemporary clinical trials","volume":"155 ","pages":"Article 108001"},"PeriodicalIF":1.9000,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contemporary clinical trials","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1551714425001958","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Military service members admitted to inpatient psychiatry for self-injurious thoughts and behaviors (SITBs) represent an at-risk group for continued SITBs and rehospitalizations in the post-hospital discharge period. Yet, there is a paucity of evidence-based interventions designed to be delivered on inpatient psychiatric units to reduce the risk of post-discharge SITBs. To address this gap, our group developed Written Exposure Therapy for Suicide Prevention (WET-SP), which is based on the written disclosure paradigm. This paper describes the design, methodology, and protocol of a randomized controlled trial. The primary objective of this study is to evaluate the efficacy of a novel, brief, scalable, cognitive behavioral therapy—WET-SP—in reducing the incidence and severity of SITBs in active duty military service members, veterans, and their adult military beneficiaries following a psychiatric hospitalization due to suicide ideation, suicide plans, or a suicide attempt.
期刊介绍:
Contemporary Clinical Trials is an international peer reviewed journal that publishes manuscripts pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from disciplines including medicine, biostatistics, epidemiology, computer science, management science, behavioural science, pharmaceutical science, and bioethics. Full-length papers and short communications not exceeding 1,500 words, as well as systemic reviews of clinical trials and methodologies will be published. Perspectives/commentaries on current issues and the impact of clinical trials on the practice of medicine and health policy are also welcome.